Status:
COMPLETED
Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite
Lead Sponsor:
Harvard School of Public Health (HSPH)
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
Conditions:
HIV/AIDS
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.
Detailed Description
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood. The pr...
Eligibility Criteria
Inclusion
- Perinatal HIV infection as documented in the medical record;
- At or beyond their 18th birthday at the time of informed consent with no upper age limit;
- Willingness to provide access to existing medical records; and
- Willingness to participate and provide legal consent
Exclusion
- Prisoner status
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
334 Patients enrolled
Trial Details
Trial ID
NCT03279185
Start Date
November 1 2017
End Date
May 31 2025
Last Update
June 27 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California
Los Angeles, California, United States, 90033
2
David Geffen School of Medicine at UCLA
Los Angeles, California, United States, 90095
3
Emory University School of Medicine
Atlanta, Georgia, United States, 30322
4
Rush University Cook County Hospital Chicago
Chicago, Illinois, United States, 60612